Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001683168-21-005280
Filing Date
2021-11-08
Accepted
2021-11-05 17:46:50
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 pharmacyte_s3.htm S-3 421209
2 OPINION AND CONSENT OF BALLARD SPAHR, LLP pharmacyte_ex0501.htm EX-5.1 12182
3 CONSENT pharmacyte_ex2301.htm EX-23.1 1951
4 GRAPHIC image_001.jpg GRAPHIC 5911
5 GRAPHIC image_002.jpg GRAPHIC 15223
6 GRAPHIC image_003.jpg GRAPHIC 23383
7 GRAPHIC image_007.jpg GRAPHIC 2144
8 GRAPHIC image_008.jpg GRAPHIC 20496
9 GRAPHIC image_012.jpg GRAPHIC 14125
  Complete submission text file 0001683168-21-005280.txt   549307
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Filer) CIK: 0001157075 (see all company filings)

EIN.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
Type: S-3 | Act: 33 | File No.: 333-260849 | Film No.: 211385909
SIC: 2836 Biological Products, (No Diagnostic Substances)